🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device

RecruitingNAAges 20 Years - anyAllNational Cheng-Kung University Hospital
NCT06103630 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Oropharyngeal muscle training has emerged as a novel adjunctive treatment approach, involving training of the swallowing muscle group and tongue muscles to prevent tongue collapse, reduce tongue base volume during sleep, and strengthen muscle tension. Therefore, the objective is to assess changes in oropharyngeal muscle strength, ultrasonographic tongue morphology, severity of sleep related breathing interruptions, clinical symptoms, and correlations among these factors. Oropharyngeal muscle training for patients with residual OSA using MAD can significantly 1. increase muscle strength and endurance. 2. reduce the severity of sleep-related breathing interruptions. 3. decrease clinical symptoms. 4. improve tongue morphology.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * OSA patients * Aged over 20 years * Wearing MAD (The amount of MAD is at least 50% of the maximum amount that the patient can achieve.) Exclusion Criteria: * Body Mass Index (BMI) ≧ 35 * Pregnancy * Severe obstructive or restrictive lung disease * Exercise with high-risk cardiovascular disease * History of central or peripheral neurological disease resulting in an inability to perform exercise prescriptions * Musculoskeletal or psychological disorders that prevent the performance of exercise prescriptions * Chronic illnesses that are ongoing or not yet controlled
💊

What it tests

  • Oropharyngeal Exercises
  • Mandibular advancement device
📍

Where

1 site
National Cheng Kung University Hospital
Tainan, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy